Search Tag: Breast
2021 03 Jun
Breast cancer has now overtaken lung cancer as the world’s mostly commonly-diagnosed cancer, according to statistics released by the International Agency for Research on Cancer (IARC) in December 2020. Women often initially detect breast cancers themselves, either by self-examination (25%) or by accident (18%). According to a 2018 survey of...Read more
2021 11 Apr
A recent study has shown that women with breast or endometrial cancer have increased levels of obstructive sleep apnoea (OSA). Researchers from the Ludwig Engel Centre for Respiratory Research, the Westmead Institute for Medical Research, and the University of Sydney, Australia, found that various epidemiological studies reported increased mortality...Read more
2021 22 Mar
Researchers from the University of Liverpool and the Leeds Teaching Hospitals presented results from a study on “Patient and Staff Acceptability of Prophylactic Skin Care: A qualitative service evaluation regarding patient and staff acceptance of prophylactic skin care for breast cancer patients undergoing radiotherapy” at the Annual Radiotherapy and...Read more
2015 26 Feb
The amount of clinical proof for the efficacy of Tomosynthesis in screening is significantly larger than the proof available in the early days of the transition from analog mammography to FFDM. Results from studies in Europe using Tomosynthesis in population based screening and results from screening with Tomosynthesis in the USA are concordant...Read more
2015 07 Feb
SuperSonic Imagine, a French company specialising in ultrasound medical imaging equipment, has signed an exclusive partnership with Konica Minolta, Inc. to distribute its Aixplorer® ultrasound system in Japan. According to SuperSonic, this partnership significantly increases the company’s geographical coverage. Japan is the third largest ultrasound...Read more
2014 21 Mar
Two separate analyses of Feasibility Study data presented at the European Congress of Radiology 2014 Seno Medical Instruments, Inc., the company pioneering development of opto-acoustic (OA) imaging as a tool to improve the process of diagnosing breast cancer, has announced that two analyses of outcomes from a US Feasibility Study of its investigational...Read more
2014 28 Jan
With an emphasis on improving lives, Hologic is focused on bringing the latest in diagnostic innovations to the fast growing Gulf region Hologic, Inc., a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems and surgical products, with an emphasis on serving the healthcare needs of women, will feature...Read more
2014 23 Jan
New IMPAX Agility, ICIS and next generation MUSICA bring barriers down across healthcare, for 'Images without boundaries' New IMPAX Agility state-of-the art imaging platform unites the functionality of disparate systems within one solution. ICIS helps eliminate boundaries to advance universal image and data sharing throughout the care continuum....Read more
2014 09 Jan
Delphinus Medical Technologies, Inc., innovator and developer of a new ultrasound platform that images the entire breast, has received 510(k) clearance from the U.S. Food and Drug Administration for the SoftVueTM whole breast ultrasound tomography system, approved for diagnostic breast imaging. Delphinus is the first company to design and manufacture...Read more
2013 03 Dec
Digital breast tomosynthesis (DBT) led to reduced recall rates and increased cancer detection in a large breast cancer screening programme, according to a study presented today at the annual meeting of the Radiological Society of North America (RSNA). While digital mammography is the gold standard for breast cancer screening, it may result in suspicious...Read more
2013 17 Sep
Growing number of peer-reviewed clinical publications document significant advantages of H ologic® tomosynthesis; Now, Hologic has further advanced tomosynthesis with faster and lower-dose options including the C-View™ software option for 2D imaging and the Affirm™ tomosynthesis biopsy procedure. Tomosynthesis is going from strength...Read more
2013 13 Jun
New analysis of breast cancer mortality data over almost 40 years concludes that breast cancer screening does not yet show an effect on mortality statistics. The research, published in the Journal of the Royal Society of Medicine, analysed mortality trends before and after the introduction of the UK's National Health Service Breast Screening Programme...Read more
2013 11 Jun
Sectra has announced that it will deliver a centralised PACS and vendor neutral archiving solution (VNA) for digital mammography throughout New Zealand. The national breast screening programme in New Zealand, BreastScreen Aotearoa, is establishing a centralised electronic picture archiving and communications system (PACS) that can store and...Read more
2013 24 May
Hologic has announced that the first large-scale observational study in a U.S. clinical practice comparing breast cancer screening with Hologic's 3D mammography technology (breast tomosynthesis) with conventional 2D mammography alone showed a significant reduction in recall rates and a sizeable increase in cancer detection, particularly invasive cancer,...Read more
2013 13 May
Microwave imaging can be used to monitor how well treatment for breast cancer is working, finds new research published in BioMed Central’s open access journal Breast Cancer Research. Microwave tomography, a low cost and repeatable technique, was able to distinguish between breast cancer, benign growths, and normal tissue. Eight women with breast...Read more
2013 09 May
Hologic has announced the publication of the final results of a large-scale prospective study comparing breast cancer screening using Hologic's 2D mammography plus tomosynthesis (Breast Tomosynthesis) with conventional 2D mammography published online in advance of print by The Lancet Oncology. The study, "Integration of 3D digital mammography with...Read more
2013 24 Apr
Researchers at the University of California, San Diego School of Medicine have shown that a new imaging dye is an effective agent in detecting and mapping cancers that have reached the lymph nodes. The radioactive dye, called Technetium Tc-99m tilmanocept, successfully identified cancerous lymph nodes and did a better job of marking cancers than the...Read more
2013 22 Apr
Hologic has announced that a new study published online by European Radiology supports the use of breast tomosynthesis in combination with 2-dimensional (2D) imaging in breast cancer screening programmes using independent double reading with arbitration. The study, " Prospective Trial Comparing Full-field Digital Mammography (FFDM) versus Combined...Read more
2013 18 Apr
Mammography, the gold standard of breast cancer screening, reduces breast cancer mortality, but has important limitations. Critics point to reduced sensitivity for women with dense breasts, a high rate of false positives leading to excessive biopsies, and concerns about long-term effects of repeated radiation. The authors of a review published...Read more
2013 16 Apr
Navidea Biopharmaceuticals, a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, has announced U.S. Food and Drug Administration (FDA) approval of Lymphoseek® (technetium Tc 99m tilmanocept) Injection, which is indicated for use in lymphatic mapping procedures to assist in the localisation of lymph nodes draining a primary...Read more
2013 21 Mar
Fewer breast imaging facilities in the United States, in addition to ongoing controversies surrounding breast cancer screening, has suppressed growth in the U.S. breast imaging systems market, according to Frost & Sullivan. However, analysts anticipate modest expansion, driven by the increasing demand for breast imaging equipment due to the growing...Read more